First Report of New Delhi Metallo-β-Lactamase Carbapenemase–Producing Acinetobacter baumannii in Peru

Authors

Claudio Rocha, U. S. Naval Medical Research Unit No 6
Manuela Bernal, U. S. Naval Medical Research Unit No 6
Enrique Canal, U. S. Naval Medical Research Unit No 6
Paul Rios, U. S. Naval Medical Research Unit No 6
Rina Meza, U. S. Naval Medical Research Unit No 6
Miguel Lopez, U. S. Naval Medical Research Unit No 6
Rosa Burga, U. S. Naval Medical Research Unit No 6
Ricardo Abadie, U. S. Naval Medical Research Unit No 6
Melita Pizango, U. S. Naval Medical Research Unit No 6
Elia Diaz, Hospital Regional de Loreto
Alexander Briones, Hospital Regional de Loreto
Cesar Ramal-Asayag, Hospital Regional de Loreto, Universidad Nacional de la Amazonia Peruana
William Vicente, Instituto Nacional de Enfermedades Neoplasicas
James Regeimbal, U. S. Naval Medical Research Unit No 6
Andrea McCoy, U. S. Naval Medical Research Unit No 6

Date of this Version

1-21-2019

Comments

This document is a U.S. government work and is not subject to copyright in the United States.

Abstract

Here we report the first incidence of New Delhi metallo-β-lactamase (NDM-1)–producing Acinetobacter baumannii in Peru, identified via a strain-based nosocomial surveillance project carried out in Lima and Iquitos. The bla_NDM-1 gene was detected by multiplex polymerase chain reaction (PCR) and confirmed by loci sequencing. Acinetobacter baumannii is a nearly ubiquitous and promiscuous nosocomial pathogen, and the acquisition of bla_NDM-1 by A.baumannii may facilitate an increase in the prevalence of this important resistance marker in other nosocomial pathogens.